APA (7th ed.) Citation

Stöth, M., Müller-Diesing, F., Mack, P., Ackermann, L., Metz, C., Grunz, J., . . . Scherzad, A. (2025). Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker. International Journal of Molecular Sciences, 26(18), 9154. https://doi.org/10.3390/ijms26189154

Chicago Style (17th ed.) Citation

Stöth, Manuel, et al. "Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker." International Journal of Molecular Sciences 26, no. 18 (2025): 9154. https://doi.org/10.3390/ijms26189154.

MLA (9th ed.) Citation

Stöth, Manuel, et al. "Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker." International Journal of Molecular Sciences, vol. 26, no. 18, 2025, p. 9154, https://doi.org/10.3390/ijms26189154.